"Oncogene Proteins v-abl" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transforming proteins encoded by the abl oncogenes. Oncogenic transformation of c-abl to v-abl occurs by insertional activation that results in deletions of specific N-terminal amino acids.
|Oncogene Proteins v-abl
- Oncogene Proteins v-abl
- Oncogene Proteins v abl
- Proteins v-abl, Oncogene
- v-abl, Oncogene Proteins
- v-abl Proteins
- v abl Proteins
- abl Oncogene Proteins
- Oncogene Proteins, abl
- Oncogene Products v-abl
- Oncogene Products v abl
- Products v-abl, Oncogene
- v-abl, Oncogene Products
Below are MeSH descriptors whose meaning is more general than "Oncogene Proteins v-abl".
Below are MeSH descriptors whose meaning is more specific than "Oncogene Proteins v-abl".
This graph shows the total number of publications written about "Oncogene Proteins v-abl" by people in this website by year, and whether "Oncogene Proteins v-abl" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Oncogene Proteins v-abl" by people in Profiles.
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat Struct Mol Biol. 2010 Apr; 17(4):519-27.
SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL. J Biol Chem. 2001 Jan 26; 276(4):2451-8.